Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Fla.
Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Fla.
J Thorac Cardiovasc Surg. 2021 Sep;162(3):710-720.e1. doi: 10.1016/j.jtcvs.2020.06.016. Epub 2020 Jun 25.
Because patients' preoperative nutritional status influences the outcomes, we have used a preoperative nutrition program for surgical patients for a 2-year period and compared the results with those from a cohort treated in the previous 2 years.
We retrospectively reviewed curative thoracic neoplasm resections from July 15, 2016, to July 15, 2018, in patients who had received a preoperative nutritional-enhanced recovery after surgery (N-ERAS) protocol. The protocol consisted of 5 days of an oral immunonutrition drink 3 times daily, daily receipt of probiotics, and a carbohydrate-loading drink the night before surgery. The historical control cohort (standard group) included those patients who had undergone surgery by the same surgeon during the previous 24 months. We excluded patients who had undergone esophageal, diagnostic, benign, emergency, or palliative procedures. Nonparametric and parametric statistical tests were used to analyze the data.
The data from 462 patients were analyzed: 229 N-ERAS patients and 233 standard patients. No significant demographic or caseload differences were found between the 2 groups. The major significant outcome differences included fewer postoperative complications (30 [13.1%] in the N-ERAS group vs 60 [25.8%] in the standard group; P < .001) and shorter hospital stays (3.8 ± 1.9 days for the N-ERAS group vs 4.4 ± 2.6 days for the standard group; P = .001). Use of the N-ERAS protocol resulted in a 16% reduction ($2198; P < .001) in the mean direct hospital costs/patient. Consequently, for the N-ERAS cohort, the hospital was likely saved $503,342 during the 2-year period for the 229 patients just by using the N-ERAS protocol.
Thoracic surgeons should consider using the nontoxic, patient-compliant N-ERAS protocol for their patients, with an expectation of improved clinical results at lower hospital costs-an important consideration when exploring methods to decrease costs because hospitals are increasingly being paid by a negotiated prospective bundled payment reimbursement model.
由于患者术前的营养状况会影响治疗效果,我们对手术患者实施了为期 2 年的术前营养方案,并将结果与前 2 年接受治疗的患者进行比较。
我们回顾性分析了 2016 年 7 月 15 日至 2018 年 7 月 15 日期间接受术前营养增强型加速康复外科(N-ERAS)方案的接受根治性胸部肿瘤切除术患者的临床资料。该方案包括口服免疫营养 5 天,每天服用益生菌,手术前一天晚上服用碳水化合物负荷饮料。历史对照组(标准组)包括在此前 24 个月内由同一位外科医生进行手术的患者。我们排除了接受食管、诊断、良性、急诊或姑息性手术的患者。采用非参数和参数统计检验对数据进行分析。
共分析了 462 例患者的数据:229 例 N-ERAS 患者和 233 例标准患者。两组间无显著的人口统计学或病例量差异。主要的显著结果差异包括术后并发症较少(N-ERAS 组 30 例[13.1%],标准组 60 例[25.8%];P<0.001)和住院时间较短(N-ERAS 组 3.8±1.9 天,标准组 4.4±2.6 天;P=0.001)。N-ERAS 方案的使用使每位患者的平均直接住院费用降低了 16%(2198 美元;P<0.001)。因此,在 2 年期间,对于 229 例 N-ERAS 患者,仅通过使用 N-ERAS 方案,医院就可能节省 503342 美元。
胸外科医生应考虑为患者使用无毒、患者依从性好的 N-ERAS 方案,以获得更好的临床效果和降低住院费用——在探索降低成本的方法时,这是一个重要的考虑因素,因为医院越来越多地采用协商后捆绑支付的报销模式。